Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland

por Barbier, Michaela, Durno, Nicholas, Bennison, Craig, Örtli, Mathias, Knapp, Christian, Schwenkglenks, Matthias
Publicado 2021